Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours have?
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours has 194 citations in the OpenAlex counts ScholarIQ stores.
When was Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours published?
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours has 2010 year in the ScholarIQ index.
What is the open-access status of Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours?
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours has hybrid oa status in the ScholarIQ index.
What is the DOI of Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours?
The DOI for Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours is on the source record.
What is the PMID of Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours?
The PMID for Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours is on the source record.
What is the OpenAlex record for Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours?
The OpenAlex for Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours is on the source record.